CVASTHERA
CVasThera is a biopharmaceutical company specializing in the development of novel therapies for cardiovascular and bowel pathologies. It holds an exclusive global license for two patents resulting from four years of joint research between INSERM (French National Institute of Health and Medical Research), the École des Mines d’Albi (a French engineering school) and the GALA platform.
CVASTHERA
Industry:
Biotechnology Pharmaceutical
Founded:
2016-07-29
Address:
Castres, Midi-Pyrenees, France
Country:
France
Website Url:
http://www.cvasthera.com
Total Employee:
1+
Status:
Active
Contact:
+33 (0)6 69 59 45 39
Email Addresses:
[email protected]
Total Funding:
1.57 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apple Mobile Web Clips Icon Font Awesome Apache ThemePunch OVH OVH Mail
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.cvasthera.com
- Host name: cluster020.hosting.ovh.net
- IP address: 46.105.57.169
- Location: Saint-Ouen France
- Latitude: 48.9067
- Longitude: 2.3339
- Timezone: Europe/Paris
- Postal: 93400
More informations about "CVasThera"
CVASTHERA pharmaceutical
CVasThera was founded in 2016 by highly experienced pharmaceutical industry professionals, with a world-class track record of CV drug discovery, drug development, clinical trials, and …See details»
CVasThera - Crunchbase Company Profile & Funding
CVasThera is a biopharmaceutical company specializing in the development of novel therapies for cardiovascular and bowel pathologies. It holds an exclusive global license for two patents …See details»
CVASTHERA pharmaceutical
Based on a strong experience of founders, CVasThera invests in the valuation of projects by itself or through partnerships. VIEW LATEST PROJECTS. contact information. En Rouget, …See details»
CVasThera Company Profile 2024: Valuation, Funding & Investors
CVasThera General Information Description. Provider of a biopharmaceutical platform intended to develop drugs for the treatment of Crohn's disease. The company's platform specializes in the …See details»
CVasThera | VentureRadar
CVasThera is a early clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for cardiovascular and bowel pathologies. …See details»
CVasThera Company Profile - Office Locations, Competitors ... - Craft
CVasThera is a biopharmaceutical company that develops therapies for cardiovascular and bowel pathologies. It focuses on atrial fibrillation, post-myocardial infarction remodeling, thrombotic …See details»
CVasThera - Crunchbase
CVasThera is a biopharmaceutical company that specializes in the development of novel therapies for cardiovascular and bowel pathologies. Search Crunchbase. Start Free Trial . …See details»
CVasThera - Tech Stack, Apps, Patents & Trademarks - Crunchbase
CVasThera is a biopharmaceutical company that specializes in the development of novel therapies for cardiovascular and bowel pathologies. Search Crunchbase. Start Free Trial . …See details»
CVASTHERA Company Profile | LABRUGUIERE, OCCITANIE, France ...
Find company research, competitor information, contact details & financial data for CVASTHERA of LABRUGUIERE, OCCITANIE. Get the latest business insights from Dun & Bradstreet. D&B …See details»
CVasThera - Tracxn
CVasThera | Founded by Bruno Grand, Sylvie Grand in the year 2016 · Manufacturer of drugs for multiple therapeutic areasSee details»
CVasThera - Overview, News & Competitors | ZoomInfo.com
CVasThera was founded in 2016 by highly experienced pharmaceutical industry professionals, with a world-class track record of CV drug discovery, drug development, clinical trials, and …See details»
CVasThera - VentureRadar
CVasThera is a early clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for cardiovascular and bowel pathologies. …See details»
CVasThera - Raised $1.6M Funding from 2 investors - Tracxn
Nov 29, 2023 CVasThera has raised a total funding of $1.6M over 1 round from 2 investors. Investors include Bpifrance and OCSEED. Their latest funding round was of $1.6M on Mar 03, …See details»
CVasThera - Products, Competitors, Financials, Employees, …
CVasThera focuses on the development and optimization of biopharmaceutical projects within the healthcare sector. Use the CB Insights Platform to explore CVasThera's full profile. …See details»
CVasThera - Contacts, Employees, Board Members, Advisors
CVasThera is a biopharmaceutical company that specializes in the development of novel therapies for cardiovascular and bowel pathologies. Search Crunchbase. Start Free Trial . …See details»
CVasThera - Founders and Board of Directors - Tracxn
CVasThera's founders include Bruno Le Grand and Sylvie Le Grand.See details»
Vagus nerve stimulation pioneers talk RESET-RA trial | Northwell …
1 day ago What if the key to treating chronic diseases like rheumatoid arthritis wasn't a drug but a tiny electrical device? That's the promise of vagus nerve stimulation (VNS), a …See details»
CVasThera - Funding, Financials, Valuation & Investors - Crunchbase
CVasThera is a biopharmaceutical company that specializes in the development of novel therapies for cardiovascular and bowel pathologies. Search Crunchbase. ... How much funding …See details»
VASTHERA - VentureRadar
"Vasthera is a pharmaceutical company that develops the first-in-class synthetic therapeutics targeting the vascular hyperplasia. We are: Developing the drug candidates for pulmonary …See details»
Top CVasThera Competitors and Alternatives | Craft.co
CVasThera's main competitors include UCB, Genentech, Cipla and Cadila Pharmaceuticals. Compare CVasThera to its competitors by revenue, employee growth and other metrics at Craft.See details»